Peptide Therapy

CJC-1295

Amplify Recovery Signals

Choose how to add this to your plan:
← Back to Menu
01

What It Treats

Slow recovery
Poor sleep quality
Age-related GH decline
Body recomposition
Lean mass support
Workout recovery
CJC-1295 mechanism
02

How It Works

CJC-1295 No DAC is a modified growth hormone-releasing hormone signal used in provider-guided protocols to support endogenous GH pulses and downstream IGF-1 activity. It is evaluated carefully because GH-axis response varies by patient and can overlap with other hormone or metabolic plans.

03

Mechanism of Action

CJC-1295 mechanism of action

CJC-1295 belongs in the same biological neighborhood as Sermorelin: it is a GHRH-style signal aimed at the pituitary. The visual shows a preserved pulse pattern rather than a flat hormone replacement line. That is the patient-facing concept LifeSpann should emphasize. For CJC-1295 No DAC specifically, the public page should stay careful: much of the human literature is on long-acting CJC-1295 with DAC, while No DAC is used clinically as a shorter-acting modified GRF-style option. The provider decides whether GH-axis signaling is appropriate, whether labs support it, and whether another peptide would be cleaner.

Backed by research:
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults

In randomized ascending-dose studies of long-acting CJC-1295, healthy adults had dose-dependent increases in GH and IGF-1 with no serious adverse reactions reported; these data support GH-axis biology but are not identical to No DAC protocols.

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog

A single CJC-1295 injection increased mean GH secretion and IGF-1 while preserving pulsatile GH secretion, reinforcing the concept that GHRH analogs can support GH signaling without simply replacing GH.

← Browse More Services
04

The Transformation

CJC-1295 before and after
Before After

The transformation image is about recovery capacity, not a before-and-after promise. Patients who ask about CJC usually describe slow recovery, poor sleep rhythm, reduced training tolerance, and body-composition frustration. The intended discussion is whether a GH-axis support signal could help create a better recovery environment when nutrition, sleep, resistance training, metabolic health, and hormone status are also addressed. If glucose trends, edema, headaches, sleep apnea, or IGF-1 response look wrong, the safer move is to adjust or stop rather than push harder.

Backed by research:
Activation of the GH/IGF-1 axis by CJC-1295, a long acting GHRH analog, results in serum protein profile changes in normal adult subjects

Proteomic analysis after CJC-1295 exposure identified serum protein changes associated with GH/IGF-1 activity, supporting measurable downstream biological effects of GH-axis activation.

05

What to Expect

01
Week 1

Provider Fit Review

The visit focuses on goals, GH-axis history, glucose/metabolic risk, current hormone therapy, and whether CJC No DAC is appropriate versus another recovery or sleep-support option.

02
Weeks 2-8

Recovery Signal Window

Patients who respond may notice deeper recovery, improved training tolerance, better sleep rhythm, or gradual body-composition support. It is not expected to feel like an immediate stimulant.

03
Weeks 8-12

Response & Lab Review

Provider reviews symptom response, tolerability, and labs when indicated. If sleep, glucose, edema, headaches, or IGF-1 trends are not appropriate, the protocol may be adjusted or stopped.

06

Your Protocol at a Glance

CJC-1295 protocol timeline
07

Ideal For

Patients who want a provider-supervised growth hormone secretagogue discussion focused on recovery, sleep, and body composition, especially when labs and history support GH-axis evaluation.

09

Safety & Considerations

  • Published human evidence is strongest for CJC-1295 with DAC; No DAC protocols require careful provider judgment and informed discussion
  • Provider review required for active malignancy, pituitary disease, abnormal IGF-1, severe untreated sleep apnea, or unexplained headaches/vision changes
  • Patients with diabetes, insulin resistance, edema, carpal-tunnel symptoms, or glucose-lowering medications may need closer monitoring
  • Pregnancy, trying to conceive, and breastfeeding require provider clearance before any peptide protocol
  • Do not combine with Sermorelin, Tesamorelin, exogenous growth hormone, or other GH-axis products unless the provider specifically writes that plan
10

Frequently Asked Questions

Ready to Start CJC-1295?

Add this to your plan so we can confirm the right protocol, pricing, and next steps at your consultation. Or book directly.

Cancellation Policy: A $50 non-refundable deposit is required to confirm your appointment for all consultations — our front desk will reach out to collect it after you book. The deposit is applied toward your visit cost. We require at least 24 hours' notice for cancellations or changes. No-shows or late cancellations will forfeit the deposit. By booking, you agree to these terms.

Business hours: Mon–Thu 8am–6pm · Fri 8am–12pm